Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-κB inhibition

详细信息    查看全文

• 作者：Francesca Benedetti ; Sergio Davinelli ; Selvi Krishnan…
• 关键词：Hydrogen sulfide (H2S) ; NaHS ; GYY4137 ; MCP ; 1 ; Mycoplasma fermentans ; Monocytes/macrophages ; NF ; κB
• 刊名：Journal of Translational Medicine
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：12
• 期：1
• 全文大小：513 KB
• 参考文献：1. Li, L, Rose, P, Moore, PK (2011) Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51: pp. 169-187 CrossRef
  2. Predmore, BL, Lefer, DJ, Gojon, G (2012) Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal 17: pp. 119-140 CrossRef
  3. Szabó, C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: pp. 917-935 CrossRef
  4. Bian, JS, Yong, QC, Pan, TT, Feng, ZN, Ali, MY, Zhou, S, Moore, PK (2006) Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316: pp. 670-678
  5. Papapetropoulos, A, Pyriochou, A, Altaany, Z, Yang, G, Marazioti, A, Zhou, Z, Jeschke, MG, Branski, LK, Herndon, DN, Wang, R, Szabó, C (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106: pp. 21972-21977 CrossRef
  6. Bucci, M, Papapetropoulos, A, Vellecco, V, Zhou, Z, Pyriochou, A, Roussos, C, Roviezzo, F, Brancaleone, V, Cirino, G (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30: pp. 1998-2004 CrossRef
  7. Zhao, W, Zhang, J, Lu, Y, Wang, R (2001) The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20: pp. 6008-6016 CrossRef
  8. Grambow, E, Mueller Graf, F, Delyagina, E, Frank, M, Kuhla, A, Vollmar, B (2013) Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice. Platelets 25: pp. 166-174 CrossRef
  9. Mirandola, P, Gobbi, G, Sponzilli, I, Pambianco, M, Malinverno, C, Cacchioli, A, De Panfilis, G, Vitale, M (2007) Exogenous hydrogen sulfide induces functional inhibition and cell death of cytotoxic lymphocytes subsets. J Cell Physiol 213: pp. 826-833 CrossRef
  10. Fox, B, Schantz, JT, Haigh, R, Wood, ME, Moore, PK, Viner, N, Spencer, JP, Winyard, PG, Whiteman, M (2012) Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint?. J Cell Mol Med 16: pp. 896-910 CrossRef
  11. Whiteman, M, Winyard, PG (2011) Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Exp Rev Clin Pharmacol 4: pp. 13-32 CrossRef
  12. Zanardo, RC, Brancaleone, V, Distrutti, E, Fiorucci, S, Cirino, G, Wallace, JL (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: pp. 2118-2120 CrossRef
  13. Oh, GS, Pae, HO, Lee, BS, Kim, BN, Kim, JM, Kim, HR, Jeon, SB, Jeon, WK, Chae, HJ, Chung, HT (2006) Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: pp. 106-119 CrossRef
  14. Pan, LL, Liu, XH, Gong, QH, Wu, D, Zhu, YZ (2011) Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One 6: pp. e19766 CrossRef
  15. Lee, M, Schwab, C, Yu, S, McGeer, E, McGeer, PL (2009) Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging 30: pp. 1523-1534 CrossRef
  16. Hu, LF, Wong, PT, Mo
• 刊物主题：Biomedicine general; Medicine/Public Health, general;
• 出版者：BioMed Central
• ISSN：1479-5876

文摘

Background and aims Hydrogen sulfide (H2S), together with nitric oxide (NO) and carbon monoxide (CO), belongs to a family of endogenous signaling mediators termed “gasotransmitters- Recent studies suggest that H2S modulates many cellular processes and it has been recognized to play a central role in inflammation, in the cardiovascular and nervous systems. By infecting monocytes/macrophages with Mycoplasma fermentans (M.F.), a well-known pro-inflammatory agent, we evaluated the effects of H2S. Methods M.F.-infected cells were analyzed by ELISA and real time RT-PCR to detect the M.F. effects on MCP-1 and on MMP-12 expression. The role of two different H2S donors (NaHS and GYY4137) on MF-infected cells was determined by treating infected cells with H2S and then testing the culture supernatants for MCP-1 and on MMP-12 production by ELISA assay. In order to identify the pathway/s mediating H2S- anti-inflammatory activity, cells were also treated with specific pharmaceutical inhibitors. Cytoplasmic and nuclear accumulation of NF-κB heterodimers was analyzed. Results We show that H2S was able to reduce the production of pro-inflammatory cytokine MCP-1, that was induced in monocytes/macrophages during M.F. infection. Moreover, MCP-1 was induced by M.F. through Toll-like receptor (TLR)-mediated nuclear factor-κB (NF-κB) activation, as demonstrated by the fact that TLR inhibitors TIRAP and MyD88 and NF-κB inhibitor IKK were able to block the cytokine production. In contrast H2S treatment of M.F. infected macrophages reduced nuclear accumulation of NF-κB heterodimer p65/p52. Conclusions Our data demonstrate that under the present conditions H2S is effective in reducing Mycoplasma-induced inflammation by targeting the NF-κB pathway. This supports further studies for possible clinical applications.